Wyeth Hit With Securities Suit Over Menopause Drug
Wyeth has been slammed by a proposed shareholder class action alleging that the pharmaceuticals giant made false and misleading statements about its depression and menopause drug Pristiq....To view the full article, register now.
Already a subscriber? Click here to view full article